These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 12380405)

  • 41. Contraceptive efficacy and safety of DMPA-SC.
    Jain J; Jakimiuk AJ; Bode FR; Ross D; Kaunitz AM
    Contraception; 2004 Oct; 70(4):269-75. PubMed ID: 15451329
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Depo-Provera: use of a long-acting progestin injectable contraceptive in Turkish women.
    Aktun H; Moroy P; Cakmak P; Yalcin HR; Mollamahmutoglu L; Danisman N
    Contraception; 2005 Jul; 72(1):24-7. PubMed ID: 15964288
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Injectable Lunelle contraceptive being recalled.
    Cockey CD
    AWHONN Lifelines; 2002 Dec; 6(6):499. PubMed ID: 12593254
    [No Abstract]   [Full Text] [Related]  

  • 44. Monthly injectable contraceptive use by adolescents in Brazil: evaluation of clinical aspects.
    Guazzelli CA; Jacobucci MS; Barbieri M; Araújo FF; Moron AF
    Contraception; 2007 Jul; 76(1):45-8. PubMed ID: 17586136
    [TBL] [Abstract][Full Text] [Related]  

  • 45. New contraceptive methods.
    Plourd DM; Rayburn WF
    J Reprod Med; 2003 Sep; 48(9):665-71. PubMed ID: 14562628
    [TBL] [Abstract][Full Text] [Related]  

  • 46. RETIRED: Canadian contraception consensus--update on Depot Medroxyprogesterone Acetate (dmpa).
    Black A; ;
    J Obstet Gynaecol Can; 2006 Apr; 28(4):305-308. PubMed ID: 16776909
    [No Abstract]   [Full Text] [Related]  

  • 47. Contraception 2000: lunelle, an injectable combination contraceptive option.
    Shulman LP
    J Womens Health Gend Based Med; 2000 Sep; 9(7):725-9. PubMed ID: 11025864
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Is a lower-dose, subcutaneous contraceptive injectable containing depot medroxyprogesterone acetate likely to impact women's risk of HIV?
    Polis CB; Achilles SL; Hel Z; Hapgood JP
    Contraception; 2018 Mar; 97(3):191-197. PubMed ID: 29242082
    [No Abstract]   [Full Text] [Related]  

  • 49. Long-acting contraceptives in adolescents.
    Tolaymat LL; Kaunitz AM
    Curr Opin Obstet Gynecol; 2007 Oct; 19(5):453-60. PubMed ID: 17885461
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Recent developments in hormone delivery systems.
    Shulman LP; Nelson AL; Darney PD
    Am J Obstet Gynecol; 2004 Apr; 190(4 Suppl):S39-48. PubMed ID: 15105797
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The menopausal transition: how does route of delivery affect the risk/benefit ratio of hormone therapy?
    Shulman LP
    J Fam Pract; 2004 Jul; Suppl():S13-7. PubMed ID: 15251108
    [No Abstract]   [Full Text] [Related]  

  • 52. Long-acting reversible contraception in adolescents.
    Morrell K
    J Pediatr Adolesc Gynecol; 2012 Dec; 25(6):407-9. PubMed ID: 23304711
    [No Abstract]   [Full Text] [Related]  

  • 53. Progress in contraception: new technology.
    Linn ES
    Int J Fertil Womens Med; 2003; 48(4):182-91. PubMed ID: 13677551
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Subcutaneous depo-medroxyprogesterone acetate.
    Cameron S
    J Fam Plann Reprod Health Care; 2013 Apr; 39(2):75-7. PubMed ID: 23493590
    [No Abstract]   [Full Text] [Related]  

  • 55. Same-day administration of depot-medroxyprogesterone acetate injection: a retrospective chart review.
    Balkus J; Miller L
    Contraception; 2005 May; 71(5):395-8. PubMed ID: 15854642
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Progestin only contraceptives and their use in adolescents: clinical options and medical indications.
    Burkett AM; Hewitt GD
    Adolesc Med Clin; 2005 Oct; 16(3):553-67. PubMed ID: 16183539
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Urinary tract infection in the users of depot-medroxyprogesterone acetate.
    Ziaei S; Ninavaei M; Faghihzadeh S
    Acta Obstet Gynecol Scand; 2004 Oct; 83(10):909-11. PubMed ID: 15453884
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Bleeding patterns of adolescents using a combination contraceptive injection for 1 year.
    Bortolotti de Mello Jacobucci MS; Guazzelli CA; Barbieri M; Araújo FF; Moron AF
    Contraception; 2006 Jun; 73(6):594-7. PubMed ID: 16730490
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Sale and provision of injectable contraceptives in drug shops in developing countries: conclusions from a technical consultation.
    Stanback J; Lebetkin E; Orr T; Malarcher S;
    Contraception; 2015 Feb; 91(2):93-6. PubMed ID: 25604899
    [No Abstract]   [Full Text] [Related]  

  • 60. Introductory trial of the once-a-month injectable contraceptive, Cyclofem, in Indonesia.
    Pandi SP; Hadjar LN; Prihyugiharto T
    Adv Contracept; 1993 Mar; 9(1):33-40. PubMed ID: 8342452
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.